Bill Sponsor
House Concurrent Resolution 146
115th Congress(2017-2018)
Expressing the sense of Congress on the need to inform American consumers with more balanced purchasing information for prescription drugs through the disclosure of price information in direct-to-consumer (DTC) advertisements.
Introduced
Introduced
Introduced in House on Dec 20, 2018
Overview
Text
Introduced
Dec 20, 2018
Latest Action
Dec 20, 2018
Origin Chamber
House
Type
Concurrent Resolution
Concurrent Resolution
A form of legislative measure used for the regulation of business within both chambers of Congress, not for proposing changes in law. Depending on the chamber of origin, they begin with a designation of either H.Con.Res. or S.Con.Res. Joint resolutions and simple resolutions are other types of resolutions.
Bill Number
146
Congress
115
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Sponsorship by Party
Republican
Texas
House Votes (0)
Senate Votes (0)
No House votes have been held for this bill.
Summary

Expresses the sense of Congress that:

  • the efficient administration of Medicare and Medicaid encompasses federal efforts to achieve good value for funds spent in those programs;
  • the Centers for Medicare & Medicaid Services (CMS) has the authority to require direct-to-consumer television advertisements of prescription drugs and biological products to include the drug or product's list price; and
  • the proposed rule by the CMS published in the Federal Register on October 18, 2018, when finalized, shall be codified without change.
Text (1)
December 20, 2018
Actions (2)
12/20/2018
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
12/20/2018
Introduced in House
Public Record
Record Updated
Jan 11, 2023 1:40:53 PM